EVRG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Evergy Inc (EVRG) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong earnings growth outlook, improving regulatory environment, and positive analyst sentiment support this decision. While the stock is currently overbought, its bullish technical indicators and favorable options data suggest continued upward momentum. Additionally, the company's financial performance shows consistent growth, making it a solid long-term investment.
The technical indicators for EVRG are bullish. The MACD is positively expanding above 0, indicating upward momentum. The RSI is at 83.492, signaling overbought conditions, but this is consistent with strong price momentum. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at R1: 84.555 and R2: 85.85, with current price nearing R1.
BTIG initiated a Buy rating with a $99 price target, citing 6%-8% earnings growth and improving regulatory environments.
Hedge funds are significantly increasing their holdings, with a 4717.45% increase in buying over the last quarter.
Financials show YoY growth in revenue (6.59%), net income (7.80%), and EPS (5.88%).
Insiders are selling, with a 114.17% increase in selling activity over the last month.
The RSI indicates overbought conditions, which could lead to short-term price corrections.
Gross margin dropped slightly by -0.67% YoY in Q4 2025.
In Q4 2025, Evergy reported a 6.59% YoY increase in revenue, a 7.80% YoY increase in net income, and a 5.88% YoY increase in EPS. However, gross margin slightly declined by -0.67% YoY. Overall, the company demonstrated solid financial growth.
Analysts are generally bullish on Evergy. Recent ratings include a Buy from BTIG with a $99 price target, Barclays raising its target to $89 with an Overweight rating, and Citi increasing its target to $95 with a Buy rating. UBS downgraded to Neutral, citing limited upside after strong performance, but still raised the price target to $88. The consensus reflects confidence in the company's growth potential and regulatory improvements.
